Pharmaste Daily: October 4, 2026

Go to the current selection →

DAILY SELECTION · October 4, 2026

Question focus: Clinical practice. Drug cards rotate across medication classes.

QUESTION OF THE DAY

Make a choice. Understand the why.

Log in with a confirmed account to save your submitted response. Multiple-response questions require the complete correct set; this is Pharmaste practice feedback, not a claim about NABP scoring.

0 of 1 answered. Your latest responses are used for your recap; you can revisit any set.

Loading your question…

Continue with clinical practice →

DRUG OF THE DAY

sertraline

Selective serotonin reuptake inhibitor (SSRI)

Before opening the card, recall one use, one safety check and one counseling point.

Reveal the drug learning card

Names and formulations

  • Zoloft: tablet and oral concentrate; concentrate requires dilution

The oral concentrate must be diluted only with a permitted beverage immediately before use; tablet and concentrate dosing are not prepared the same way.

Common use

Major depressive disorder, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, social anxiety disorder, and premenstrual dysphoric disorder.

Mechanism of action

Selectively inhibits presynaptic serotonin reuptake, increasing serotonergic activity in the central nervous system.

Important adverse effects and monitoring

  • Boxed warning: monitor children, adolescents, and young adults for suicidal thoughts or behavior, especially early in treatment and after dose changes.
  • Monitor for serotonin syndrome, hyponatremia, abnormal bleeding, activation of mania/hypomania, and discontinuation symptoms.
  • Clinical benefit may take time; reassess adherence, response, and tolerability rather than escalating prematurely.

Patient counseling

  • Take consistently and do not stop abruptly without a tapering plan.
  • Seek help promptly for worsening mood, suicidal thoughts, severe agitation, fever with rigidity, or confusion.

Interaction to recognize

With: monoamine oxidase inhibitors (MAOIs)

Why it matters: Can precipitate life-threatening serotonin syndrome.

Practical response: Concomitant use and use within the required washout intervals are contraindicated.

Check the original sources

Selected learning points; verify current labeling for the complete prescribing information.

Featured from our existing free, reviewed collections. Revisit a concept as it returns in the rotation. Featuring a resource today does not change its original source-check date.

Browse past selections →